WM Completes Acquisition of Stericycle
WM (NYSE: WM) has completed its acquisition of Stericycle for $62.00 per share in cash, representing a total enterprise value of approximately $7.2 billion. The acquisition expands WM's environmental solutions into the healthcare market and enhances its secure information destruction services. The company projects run-rate cost synergies exceeding $125 million. Stericycle stock will cease trading on NASDAQ from November 4, 2024. The newly formed WM Healthcare Solutions division will leverage WM's expertise in logistics, technology-enabled cost optimization, and waste disposal network.
WM (NYSE: WM) ha completato l'acquisizione di Stericycle per 62,00 dollari per azione in contante, rappresentando un valore totale d'impresa di circa 7,2 miliardi di dollari. L'acquisizione espande le soluzioni ambientali di WM nel mercato sanitario e migliora i servizi di distruzione sicura delle informazioni. L'azienda prevede sinergie di costo run-rate superiori a 125 milioni di dollari. Le azioni Stericycle smetteranno di essere scambiate su NASDAQ a partire dal 4 novembre 2024. La nuova divisione WM Healthcare Solutions sfrutterà l'esperienza di WM nella logistica, nell'ottimizzazione dei costi abilitata dalla tecnologia e nella rete di smaltimento dei rifiuti.
WM (NYSE: WM) ha completado su adquisición de Stericycle por 62,00 dólares por acción en efectivo, lo que representa un valor total de empresa de aproximadamente 7.2 mil millones de dólares. La adquisición amplía las soluciones ambientales de WM en el mercado de la salud y mejora sus servicios de destrucción segura de información. La compañía proyecta sinergias de costos en run-rate superiores a 125 millones de dólares. Las acciones de Stericycle dejarán de cotizar en NASDAQ a partir del 4 de noviembre de 2024. La nueva división WM Healthcare Solutions aprovechará la experiencia de WM en logística, optimización de costos habilitados por la tecnología y red de eliminación de desechos.
WM (NYSE: WM)은 현금으로 주당 62.00달러에 Stericycle 인수를 완료하였으며, 총 기업 가치는 약 72억 달러에 해당합니다. 이번 인수는 WM의 환경 솔루션을 의료 시장으로 확장하고 안전한 정보 파기 서비스를 강화합니다. 회사는 1억 2500만 달러를 초과하는 비용 시너지를 예상하고 있습니다. Stericycle 주식은 2024년 11월 4일부터 NASDAQ에서 거래를 중단합니다. 새로 형성된 WM Healthcare Solutions 부서는 물류, 기술 기반의 비용 최적화 및 폐기물 처리 네트워크에서 WM의 전문성을 활용할 것입니다.
WM (NYSE: WM) a finalisé l'acquisition de Stericycle pour 62,00 dollars par action en espèces, représentant une valeur d'entreprise totale d'environ 7,2 milliards de dollars. Cette acquisition étend les solutions environnementales de WM au marché de la santé et améliore ses services de destruction sécurisée d'informations. La société prévoit des synergies de coûts annuelles dépassant 125 millions de dollars. Les actions de Stericycle cesseront d'être négociées sur le NASDAQ à partir du 4 novembre 2024. La nouvelle division WM Healthcare Solutions tirera parti de l'expertise de WM en matière de logistique, d'optimisation des coûts grâce à la technologie et de réseau d'élimination des déchets.
WM (NYSE: WM) hat die Übernahme von Stericycle für 62,00 Dollar pro Aktie in bar abgeschlossen, was einem Gesamtkapitalwert von etwa 7,2 Milliarden Dollar entspricht. Die Übernahme erweitert WMs Umweltlösungen auf den Gesundheitsmarkt und verbessert die sicheren Informationszerstörungsdienste. Das Unternehmen prognostiziert jährliche Kostensynergien von über 125 Millionen Dollar. Die Aktien von Stericycle werden ab dem 4. November 2024 nicht mehr an der NASDAQ gehandelt. Die neu gegründete Abteilung WM Healthcare Solutions wird WMs Fachwissen in Logistik, technologiegestützter Kostenoptimierung und Abfallentsorgungsnetzwerk nutzen.
- Acquisition valued at $7.2 billion expands into growing healthcare market
- Projected cost synergies exceeding $125 million
- Strengthens operating EBITDA and cash flows
- Leverages existing logistics and waste disposal network
- Expands service offering with medical waste and secure information destruction
- Significant capital outlay of $7.2 billion
- Integration risks with new healthcare division
- Increased exposure to regulated medical waste compliance requirements
Insights
This
The medical waste market offers stable, recurring revenue streams with high barriers to entry and strict regulatory compliance requirements. This acquisition diversifies WM's revenue base while leveraging existing infrastructure and logistics capabilities. The secure information destruction services add another valuable recurring revenue stream with cross-selling opportunities across WM's extensive customer base.
The healthcare waste management market is experiencing robust growth driven by increasing healthcare expenditure, aging populations and stricter environmental regulations. Stericycle's established presence in this sector provides WM with immediate scale and expertise. The timing is strategic as healthcare facilities increasingly outsource waste management to specialized providers.
The integration presents significant operational synergies through WM's advanced logistics network and technology infrastructure. This positions WM as a comprehensive environmental solutions provider, expanding its total addressable market while maintaining strong competitive advantages through vertical integration.
WM’s Acquisition Expands its Comprehensive Environmental Solutions into the Growing Healthcare Market While Advancing the Company’s Sustainability Commitments
“I am pleased to welcome the talented Stericycle team to WM,” said Jim Fish, president and chief executive officer, WM. “The completion of this acquisition advances our growth strategy, builds on our sustainability initiatives, and aligns with our long-term financial goals. This acquisition provides a complementary business platform in medical waste, a sector with attractive near- and long-term growth dynamics, and in secure information destruction services to further our leading suite of comprehensive waste and environmental solutions. Importantly, with its strong long-term business profile and our ability to enhance the projected financial outlook of the business through customer-centric growth and projected run-rate cost synergies exceeding
As part of WM, the regulated medical waste and secure information destruction businesses will benefit from a range of synergies, including leveraging WM’s expertise in logistics, technology-enabled cost optimization, and its leading waste disposal network, among others.
“With today’s announcement, WM is well-positioned to win in the growing medical waste industry and deliver tailored and effective solutions in secure information destruction that further our sustainability leadership,” said Rafa Carrasco, senior vice president, enterprise strategy, WM, and president, WM Healthcare Solutions division. “We look forward to delivering on the compelling strategic and financial benefits of the combined business while protecting the health, safety and well-being of the communities we serve.”
ABOUT WM
WM (WM.com) is
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
WM, from time to time, provides estimates or projections of financial and other data, comments on expectations relating to future periods and makes statements of opinion, view or belief about current and future events, circumstances or performance. This press release contains a number of such forward-looking statements, including all statements regarding results and benefits from the Stericycle acquisition; the amount, timing and ability to achieve estimated cost synergies; impact on operating EBITDA and cash flows; growth dynamics; long-term financial goals; and any other statements regarding future performance or financial results of our business. You should view these statements with caution. They are based on the facts and circumstances known to WM as of the date the statements are made. These forward-looking statements are subject to risks and uncertainties that could cause actual results to be materially different from those set forth in such forward-looking statements, including but not limited to failure to implement our optimization, automation, growth, and cost savings initiatives and overall business strategy; failure to obtain the results anticipated from strategic initiatives, investments, acquisitions, or new lines of business; failure to identify acquisition targets, consummate and integrate acquisitions, including our ability to integrate the acquisition of Stericycle and achieve the anticipated benefits therefrom, including cost synergies; legal, regulatory and other matters that may affect the costs and timing of our ability to integrate and deliver all of the expected benefits of the Stericycle acquisition; existing or new environmental and other regulations, including developments related to emerging contaminants, gas emissions, renewable energy, extended producer responsibility and our natural gas fleet; significant environmental, safety or other incidents resulting in liabilities or brand damage; failure to obtain and maintain necessary permits due to land scarcity, public opposition or otherwise; diminishing landfill capacity, resulting in increased costs and the need for disposal alternatives; failure to attract, hire and retain key team members and a high quality workforce; increases in labor costs due to union organizing activities or changes in wage- and labor-related regulations; disruption and costs resulting from severe weather and destructive climate events; failure to achieve our sustainability goals or execute on our sustainability-related strategy and initiatives, including within planned timelines or anticipated budgets due to disruptions, delays, cost increases or changes in environmental or tax regulations and incentives; focus on, and regulation of, environmental and sustainability-related disclosures, which could lead to increased costs, risk of non-compliance, brand damage and litigation risk related to our sustainability efforts; macroeconomic conditions, geopolitical conflict and large-scale market disruption resulting in labor, supply chain and transportation constraints, inflationary cost pressures and fluctuations in commodity prices, fuel and other energy costs; increased competition; pricing actions; impacts from international trade restrictions; competitive disposal alternatives, diversion of waste from landfills and declining waste volumes; weakness in general economic conditions and capital markets, including potential for an economic recession; instability of financial institutions; adoption of new tax legislation; fuel shortages; failure to develop and protect new technology; failure of technology to perform as expected; failure to prevent, detect and manage cybersecurity incidents or comply with privacy regulations; inability to adapt and manage the benefits and risks of artificial intelligence; negative outcomes of litigation or governmental proceedings, including those acquired through transactions, including the Stericycle acquisition; and operation or management decisions or developments that result in impairment charges. Please also see WM’s filings with the SEC, including Part I, Item 1A of the most recently filed Annual Report on Form 10-K, as updated by subsequent Quarterly Reports on Form 10-Q, for additional information regarding these and other risks and uncertainties applicable to its business. WM assumes no obligation to update any forward-looking statement, including financial estimates and forecasts, whether as a result of future events, circumstances or developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241101351997/en/
FOR MORE INFORMATION
Website
www.wm.com
Analysts
Ed Egl
713.265.1656
eegl@wm.com
Media
Toni Werner
media@wm.com
Source: WM
FAQ
What is the value of WM's acquisition of Stericycle?
When will Stericycle stock stop trading after WM's acquisition?
What are the expected cost synergies from WM's Stericycle acquisition?